× |
|
Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome PDF |
$40.00 |
|
$40.00 |
× |
           |
Clinical Outcomes in Children and Adolescents With Bipolar Disorder and Substance Use Disorder Comorbidity PDF |
$40.00 |
|
$40.00 |
× |
           |
Predicting Remission From Depression in Youth Receiving Outpatient Medication Management PDF |
$40.00 |
|
$40.00 |
× |
           |
Intravenous Fosphenytoin in Acute Mania PDF |
$40.00 |
|
$40.00 |
× |
           |
Blood Glucose and Schizophrenia: A Systematic Review of Prospective Randomized Clinical Trials PDF |
$40.00 |
|
$40.00 |
× |
           |
Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial) PDF |
$40.00 |
|
$40.00 |
× |
           |
Predictors of Everyday Functioning Among Older Mexican Americans vs. Anglo-Americans With Schizophrenia PDF |
$40.00 |
|
$40.00 |
× |
           |
A Randomized Controlled Trial of Relapse Prevention Therapy for First-Episode Psychosis Patients PDF |
$40.00 |
|
$40.00 |
× |
           |
The Diagnostic Challenge of Psychiatric Symptoms in Neurodegenerative Disease: Rates of and Risk Factors for Prior Psychiatric Diagnosis in Patients With Early Neurodegenerative Disease PDF |
$40.00 |
|
$40.00 |
× |
           |
Psychoeducation and Compliance in the Treatment of Schizophrenia: Results of the Munich Psychosis Information Project Study. PDF |
$40.00 |
|
$40.00 |
× |
           |
Psychoeducation Efficacy in Bipolar Disorders: Beyond Compliance Enhancement PDF |
$40.00 |
|
$40.00 |
|